All In Biotech

Drug Trial Radar · NCT02462122

Safety and Efficacy of IDP-118 in Participants With Plaque Psoriasis

A Phase 3, Multicenter, Double-Blind, Randomized, Vehicle Controlled Clinical Study to Assess the Safety and Efficacy of IDP-118 in the Treatment of Plaque Psoriasis

Last checked: Nov 20, 2026Latest source record: Oct 20, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 215 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

215

Actual

Start

Aug 19, 2015

Primary completion

Nov 9, 2016

Study completion Nov 14, 2016

Sponsor

Lead sponsor
Bausch Health Americas, Inc.Industry
Sponsor type
Industry
Collaborators
Dow Pharmaceutical Sciences
First posted
Jun 3, 2015

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Safety and Efficacy of IDP-118 in the treatment of plaque psoriasis

Conditions

  • Plaque Psoriasis

Interventions

  • IDP-118 LotionDrug

    Lotion

  • IDP-118 Vehicle LotionDrug

    Lotion

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. The Percentage of Participants With Treatment Success at Week 8Time frame: 8 weeks

Locations

16 sites in 1 country. Site status is shown where the registry gives one.

  • Valeant Site 5

    Fremont, California

  • Valeant Site 2

    Boynton Beach, Florida

  • Valeant Site 14

    North Miami Beach, Florida

  • Valeant Site 13

    Detriot, Michigan

  • Valeant Site 8

    Warren, Michigan

  • Valeant Site 10

    Fridley, Minnesota

  • Valeant Site 1

    East Windsor, New Jersey

  • Valeant Site 4

    Albuquerque, New Mexico

  • Valeant Site 12

    New York, New York

  • Valeant Site 6

    High Point, North Carolina

  • Valeant Site 3

    Portland, Oregon

  • Valeant Site 7

    Knoxville, Tennessee

  • Valeant Site 9

    College Station, Texas

  • Valeant Site 15

    Houston, Texas

  • Valeant Site 16

    Houston, Texas

  • Valeant Site 11

    Pflugerville, Texas

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.